Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13901 - 13925 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:4926 bronchiolo-alveolar adenocarcinoma RGD:3889 Rattus norvegicus (Norway rat) 24842 Tp53 mutant phenotype evidence used in manual assertion
  • PMID:26059825
DOID:6432 pulmonary hypertension HGNC:13557 Homo sapiens (human) 59272 ACE2 mutant phenotype evidence used in manual assertion
  • PMID:25225206
DOID:14115 toxic shock syndrome HGNC:6000 Homo sapiens (human) 3557 IL1RN mutant phenotype evidence used in manual assertion
  • PMID:15516267
DOID:1520 colon carcinoma HGNC:12441 Homo sapiens (human) 7298 TYMS mutant phenotype evidence used in manual assertion
  • PMID:17848948
DOID:3070 high grade glioma HGNC:2654 Homo sapiens (human) 3491 CCN1 mutant phenotype evidence used in manual assertion
  • PMID:15026334
DOID:2999 granulosa cell tumor HGNC:12680 Homo sapiens (human) 7422 VEGFA mutant phenotype evidence used in manual assertion
  • PMID:19524286
DOID:7693 abdominal aortic aneurysm RGD:621681 Rattus norvegicus (Norway rat) 64803 P2ry12 mutant phenotype evidence used in manual assertion
  • PMID:19028049
DOID:8466 retinal degeneration HGNC:9009 Homo sapiens (human) 5311 PKD2 mutant phenotype evidence used in manual assertion
  • PMID:16943309
DOID:0110197 Charcot-Marie-Tooth disease dominant intermediate B SGD:S000001709 Saccharomyces cerevisiae S288C 853870 VPS1 mutant phenotype evidence used in manual assertion
  • PMID:28357347
  • PMID:37060997
DOID:6000 congestive heart failure RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:19620082
  • PMID:22123369
DOID:10825 essential hypertension HGNC:336 Homo sapiens (human) 185 AGTR1 mutant phenotype evidence used in manual assertion
  • PMID:18604484
DOID:0050855 renal fibrosis RGD:3001 Rattus norvegicus (Norway rat) 24536 Lepr mutant phenotype evidence used in manual assertion
  • PMID:27465994
DOID:576 proteinuria RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:10844603
DOID:1612 breast cancer HGNC:259 Homo sapiens (human) 133 ADM mutant phenotype evidence used in manual assertion
  • PMID:16841081
DOID:10966 lipoid nephrosis RGD:68949 Rattus norvegicus (Norway rat) 116553 Il13 mutant phenotype evidence used in manual assertion
  • PMID:17429054
DOID:1612 breast cancer HGNC:11896 Homo sapiens (human) 7128 TNFAIP3 mutant phenotype evidence used in manual assertion
  • PMID:28892081
DOID:2920 membranoproliferative glomerulonephritis RGD:3645 Rattus norvegicus (Norway rat) 24770 Ccl2 mutant phenotype evidence used in manual assertion
  • PMID:10411686
DOID:552 pneumonia RGD:3684 Rattus norvegicus (Norway rat) 25715 Slc11a2 mutant phenotype evidence used in manual assertion
  • PMID:21278260
DOID:790 ocular hypotension RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:24583339
DOID:3021 acute kidney failure RGD:61897 Rattus norvegicus (Norway rat) 58949 Ptafr mutant phenotype evidence used in manual assertion
  • PMID:2538527
DOID:2841 asthma RGD:1303284 Rattus norvegicus (Norway rat) 312896 Trpa1 mutant phenotype evidence used in manual assertion
  • PMID:31969645
DOID:234 colon adenocarcinoma HGNC:1919 Homo sapiens (human) 1108 CHD4 mutant phenotype evidence used in manual assertion
  • PMID:28486105
DOID:5637 pancreatic adenosquamous carcinoma HGNC:11768 Homo sapiens (human) 7042 TGFB2 mutant phenotype evidence used in manual assertion
  • PMID:21366804
DOID:594 panic disorder RGD:2845 Rattus norvegicus (Norway rat) 24473 Htr1a mutant phenotype evidence used in manual assertion
  • PMID:21421022
DOID:9206 Barrett's esophagus RGD:3726 Rattus norvegicus (Norway rat) 25273 Smo mutant phenotype evidence used in manual assertion
  • PMID:23108119
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025